Mantle Cell Lymphoma
Phase II study of low intensity allogeneic transplantation in Mantle Cell Lymphoma.
To assess the safety and efficacy of Reduced Intensity Conditioning (RIC) transplantation as part of the initial treatment of Mantle Cell Lymphoma (MCL).
A Parallel Randomised Phase II Trial Of CHOP Chemotherapy With Or Without Bortezomib In Relapsed Mantle Cell Lymphoma
PiCLLe - Phase I/II clinical trial to assess the efficacy and safety of olaparib, a PARP-inhibitor, in relapsed and refractory Chronic Lymphocytic Leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T-Prolymphocytic Leukaemia and Mantle Cell Lymphoma.